JP2005529960A5 - - Google Patents

Download PDF

Info

Publication number
JP2005529960A5
JP2005529960A5 JP2004514431A JP2004514431A JP2005529960A5 JP 2005529960 A5 JP2005529960 A5 JP 2005529960A5 JP 2004514431 A JP2004514431 A JP 2004514431A JP 2004514431 A JP2004514431 A JP 2004514431A JP 2005529960 A5 JP2005529960 A5 JP 2005529960A5
Authority
JP
Japan
Prior art keywords
antigen
vaccine
propionibacterium
tuberculosis
ienseni
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004514431A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005529960A (ja
JP4521687B2 (ja
Filing date
Publication date
Priority claimed from AUPS3124A external-priority patent/AUPS312402A0/en
Priority claimed from AUPS3152A external-priority patent/AUPS315202A0/en
Priority claimed from AU2002952793A external-priority patent/AU2002952793A0/en
Application filed filed Critical
Priority claimed from PCT/AU2003/000775 external-priority patent/WO2004001022A1/en
Publication of JP2005529960A publication Critical patent/JP2005529960A/ja
Publication of JP2005529960A5 publication Critical patent/JP2005529960A5/ja
Application granted granted Critical
Publication of JP4521687B2 publication Critical patent/JP4521687B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004514431A 2002-06-21 2003-06-20 プロバイオティクス、プロピオニバクテリウム・イエンセニー702 Expired - Fee Related JP4521687B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPS3124A AUPS312402A0 (en) 2002-06-21 2002-06-21 Probiotic propionibacterium
AUPS3152A AUPS315202A0 (en) 2002-06-24 2002-06-24 Probiotic propionibacterium
AU2002952793A AU2002952793A0 (en) 2002-11-18 2002-11-18 Oral vaccination
PCT/AU2003/000775 WO2004001022A1 (en) 2002-06-21 2003-06-20 Probiotic propionibacterium jensenii 702

Publications (3)

Publication Number Publication Date
JP2005529960A JP2005529960A (ja) 2005-10-06
JP2005529960A5 true JP2005529960A5 (https=) 2006-08-24
JP4521687B2 JP4521687B2 (ja) 2010-08-11

Family

ID=30003395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004514431A Expired - Fee Related JP4521687B2 (ja) 2002-06-21 2003-06-20 プロバイオティクス、プロピオニバクテリウム・イエンセニー702

Country Status (5)

Country Link
US (1) US7427397B2 (https=)
EP (1) EP1527159A4 (https=)
JP (1) JP4521687B2 (https=)
NZ (1) NZ537242A (https=)
WO (1) WO2004001022A1 (https=)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175305A1 (en) * 2002-01-08 2003-09-18 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
US7291326B2 (en) 2003-01-06 2007-11-06 Nutrition Physiology Corporation Compositions and methods for reducing the pathogen content of meat and meat products
US20040028665A1 (en) 2002-01-08 2004-02-12 Garner Bryan E. Compositions and methods for inhibiting pathogenic growth
US8337861B2 (en) * 2003-01-09 2012-12-25 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
WO2007070518A2 (en) * 2005-12-13 2007-06-21 The Trustees Of The University Of Pennsylvania Bacteria-derived blis for treatment of acne
WO2008028146A2 (en) * 2006-09-01 2008-03-06 Wisconsin Alumni Research Foundation Novel protein compositions and systems for expression of desaturases
JP2008118908A (ja) * 2006-11-10 2008-05-29 Canon Inc プローブ、プローブセット、プローブ固定担体及び遺伝子検査方法
EP1952703B1 (de) * 2007-02-02 2010-08-25 May, Amadeus Alexander Produkt mit lebenden probiotischen Mikroorganismen
FR2921795B1 (fr) * 2007-10-03 2011-04-29 Gervais Danone Sa Utilisation d'une souche de bifidobacterium,pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique
KR20170059011A (ko) * 2007-11-27 2017-05-29 가부시키가이샤 메이지 유산균의 생잔성 향상제 및 생잔성 향상 방법, 및 식품 조성물
NZ596979A (en) * 2008-02-29 2012-06-29 Meiji Co Ltd Anti-allergic agent comprising a fermentation product of a propionic acid bacterium
AU2015200625B2 (en) * 2008-03-07 2017-03-16 Megmilk Snow Brand Co., Ltd. Agents for promoting secretion and/or suppressing decrease of adiponectin
NZ587285A (en) * 2008-03-07 2013-08-30 Bongrain Sa Agents for promoting secretion and/or suppressing decrease of adiponectin
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
EP2245944A1 (fr) * 2009-04-30 2010-11-03 Danisco A/S Procédé pour améliorer la digestibilité et l'assimilabilité des céréales et/ou des fibres chez un animal herbivore monogastrique
UY32802A (es) * 2009-07-23 2011-01-31 Provimi Holding B V Composiciones para reducir la metanogénesis gastrointestinal en rumiantes
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US9961914B2 (en) 2010-12-07 2018-05-08 Purac Biochem Bv Fruit ferments containing propionate and use thereof
JP5818309B2 (ja) * 2011-03-23 2015-11-18 株式会社明治 血中コレステロール低減剤
WO2014001102A1 (de) * 2012-06-26 2014-01-03 Uniwersytet Przyrodniczy W Poznaniu Propionibakterienstamm propionibacterium freundenreichii kt 021
JP5882177B2 (ja) * 2012-10-19 2016-03-09 株式会社日立製作所 生体物質回収方法及び生体物質回収装置
WO2014098764A1 (en) * 2012-12-21 2014-06-26 Conifer Living Formulas Pte Ltd Topical treatment delivery system
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
US20150352162A1 (en) 2013-01-21 2015-12-10 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
US9737592B1 (en) 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
ES3025685T3 (en) 2014-06-17 2025-06-09 Crown Laboratories Inc Genetically modified bacteria and methods for genetic modification of bacteria
CN107404925A (zh) 2015-03-05 2017-11-28 雀巢产品技术援助有限公司 用于预防或治疗婴儿或幼儿胃肠感染/炎症的组合物
WO2016168729A1 (en) * 2015-04-17 2016-10-20 Evolve Biosystems Inc. Delivering non-pathogenic, intestinally beneficial bacteria to a patient having a feeding tube
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
WO2016183319A1 (en) * 2015-05-13 2016-11-17 University Of Florida Research Foundation, Incorporated Propionibacterium fruedenreichii as a probiotic for infants
GB201509023D0 (en) * 2015-05-27 2015-07-08 Optibiotix Ltd Compositions and methods of production thereof
JP6262412B1 (ja) * 2016-04-14 2018-01-17 株式会社明治 発酵乳の製造における発酵時間の短縮方法、及び発酵乳における酸味の上昇の抑制方法
RU2631607C1 (ru) * 2016-11-22 2017-09-25 Владислав Николаевич Ласкавый Средство для профилактики лейкоза крупного рогатого скота и способ его применения
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN106587342A (zh) * 2016-12-29 2017-04-26 中国科学院城市环境研究所 一种生物修复试剂及其在去除复合污染水体中1,2‑二氯乙烷中的应用
US11571387B2 (en) * 2017-03-27 2023-02-07 Praj Industries Limited Process for the preparation of powdered probiotic formulations for monogastric animals
WO2018217764A1 (en) * 2017-05-22 2018-11-29 Kansas State University Research Foundation Microbiome transplantation
US12285437B2 (en) 2019-10-30 2025-04-29 The Research Foundation For The State University Of New York Reversing the undesirable pH-profile of doxorubicin via activation of a disubstituted maleamic acid prodrug at tumor acidity
CA3183350A1 (en) * 2020-06-23 2021-12-30 Thomas M. Hitchcock Probiotic skin formulations
WO2022124324A1 (ja) * 2020-12-09 2022-06-16 株式会社明治 アシディプロピオニバクテリウム属菌またはその処理物を含んでなる組成物
US20220367050A1 (en) * 2021-05-12 2022-11-17 Zoe Limited Predicting gut microbiome diversity
CN114216982B (zh) * 2021-12-14 2024-08-09 黑龙江飞鹤乳业有限公司 维生素b12的检测方法
CN114540235B (zh) * 2022-03-04 2023-10-31 中国海洋大学 一种诱导乳酸菌休眠态的方法及其应用
WO2026057677A1 (en) 2024-09-11 2026-03-19 Unikline B.V. A novel composition comprising adenosyl cobalamin
CN120173826B (zh) * 2025-05-20 2025-08-01 造益(昆山)生物科技有限公司 耐温费氏丙酸杆菌谢氏亚种菌株pf37及其在肠道定植共生的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5937076B2 (ja) 1977-05-26 1984-09-07 日石三菱株式会社 醗酵法ビタミンb↓1↓2の製法
US4981705A (en) * 1989-11-06 1991-01-01 Pioneer Hi-Bred International, Inc. Bacterial treatment to preserve silage
US5639659A (en) * 1992-12-29 1997-06-17 Clemson University Process for inhibiting the growth of bacteria using bacteriocins produced by Propionibacterium jensenii strain ATCC 4872
DE19630230A1 (de) 1996-07-26 1998-01-29 Bayer Ag Herstellung immunstimulierender Mittel auf Basis von Propionibakterien
US6221847B1 (en) * 1996-09-13 2001-04-24 Clemson University Composition and method for treating bacterial infection
US5989612A (en) * 1996-10-11 1999-11-23 Rodia Inc. Foods including antimycotic agent
JPH11171783A (ja) 1997-08-15 1999-06-29 Vetoquinol Sa 所定の動物に関して細胞性免疫と体重増加を生じる濃度でのバクテリアの経口投与
US6019985A (en) 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
WO1999053775A1 (en) * 1998-04-17 1999-10-28 The Board Of Regents For Oklahoma State University Propionibacterium p-63 for use in direct fed microbials for animal feeds
US6262019B1 (en) 1998-04-30 2001-07-17 Vit-Immune, L. C. Method of treatment of glutathione deficient mammals
KR20010075495A (ko) 1998-10-01 2001-08-09 추후보정 산화성 스트레스 인자의 감소
US6080401A (en) 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US6951643B2 (en) * 2001-07-24 2005-10-04 Oklahoma State University Direct-fed microbial
EP1308506A1 (en) * 2001-11-06 2003-05-07 Eidgenössische Technische Hochschule Zürich Mixtures of Propionibacterium jensenii and Lactobacillus sp. with antimicrobial activities for use as a natural preservation system
EP1374878A1 (en) 2002-06-20 2004-01-02 N.V. Nutricia Method and composition for preventing or alleviating symptoms of malabsorption from the gastrointestinal tract
CN1317385C (zh) 2003-05-30 2007-05-23 上海光明乳业股份有限公司 干酪乳杆菌Bd-II菌株及其在降低血脂方面的应用
US7279320B1 (en) 2003-06-20 2007-10-09 United States As Represented By The Secretary Of The Air Force Curlicue vaccine strain of Bacillus anthracis

Similar Documents

Publication Publication Date Title
JP2005529960A5 (https=)
US10226490B2 (en) Probiotic compositions and methods for inducing and supporting weight loss
Perdigón et al. Lactic acid bacteria and their effect on the immune system
TWI359668B (https=)
US7678777B2 (en) Composition for promoting the proliferation of Lactobacillus casei subsp. casei
CN108721337B (zh) 一种预防肿瘤化疗肠道毒性的微生物菌剂
JP2005529960A (ja) プロバイオティクス、プロピオニバクテリウム・イエンセニー702
US12472245B2 (en) Compositions and methods
US20220192246A1 (en) Composition and method for synbiotics supplement containing probiotics, digestive enzymes, prebiotics, yeast, protein, b vitamins, and flavoring agent
JP2023121755A5 (https=)
Yuan et al. Important role of Bacillus subtilis as a probiotic and vaccine carrier in animal health maintenance
WO1998042194A1 (en) Stabilized solid bacteria compositions
JPH07228536A (ja) 乳酸菌を用いた免疫賦活剤
Farid et al. Saccharomyces cerevisiae
JP3269890B2 (ja) ワクチンの効果増強剤及び効果増強食品
EP0686039B1 (en) Method of enhancing immune response to oral vaccines
CN108157595A (zh) 一种微生态制剂及其制备方法
JPH0680575A (ja) 経口免疫賦活剤
EP1796700B1 (en) Eukaryotic based synergistic formulation for gastro-intestinal disorders
Murugesan et al. Bioprocess optimization and evaluation of probiotics efficacy on growth performance of Broilers and Country Chicks
JP7663240B2 (ja) 腸管免疫賦活剤及びIgA産生促進剤
CN1853656A (zh) 具有免疫调节作用的发酵组合物
Wainwright Biological control of microbial infections and cancer in humans: Historical use to future potential
KR20250019220A (ko) 장누수증후군 개선, 치료, 또는 예방용 유산균 및 이의 용도
JP2007112805A (ja) ラクトバシラス・カゼイ亜種カゼイ増殖促進用組成物